Detection of tau spatial extent using MK6240 and flortaucipir PET
Authors:
- Guilherme PovalaGPGuilherme Povala
- Bruna BellaverBBBruna Bellaver
- Livia AmaralLALivia Amaral
- Firoza Z. LussierFLFiroza Z. Lussier
- Arthur C. MacedoAMArthur C. Macedo
- Pamela C.L. FerreiraPFPamela C.L. Ferreira
- Douglas T. LeffaDLDouglas T. Leffa
- Guilherme Bauer-NegriniGBGuilherme Bauer-Negrini
- Marina Scop MedeirosMMMarina Scop Medeiros
- Emma RuppertEREmma Ruppert
- Cecile TissotCTCecile Tissot
- Thomas K. KarikariTKThomas K. Karikari
Preprint
Abstract
INTRODUCTION: Tau PET enables in vivo quantification of neurofibrillary tangle spread, yet whether tau spatial extent (TSE) performs comparably across tracers remains unknown. METHODS: We performed a head-to-head comparison of Flortaucipir and MK6240 tau PET in 682 individuals across the AD continuum, quantifying TSE as the percentage of regional voxels exceeding a tracer-specific abnormality threshold and evaluated it as a metric of tracer comparability. RESULTS: MK6240 showed greater TSE than Flortaucipir (CU Aβ+, medial temporal lobe [MTL]: 42% vs 25%; dementia Aβ+, late neocortical: 55% vs 42%), reaching 50% detection probability at lower Aβ burden (Centiloid: MTL, 26 vs 45; late neocortical, 95 vs 118). TSE showed higher associations than SUVR with memory, Aβ PET, and plasma pTau217, particularly in the neo-late composite. Participants with intermediate tau involvement (TSE 25–50%), most below the SUVR positivity thresholds (MTL positivity 10.2–16.9%), had approximately three-fold higher odds of Aβ PET and pTau217 positivity than TSE 0–25% (ORs 2.90–3.46). 53.4% of intermediate Flortaucipir cases (TSE 25–50%) shifted to a higher MK6240 category, and 82.5% of moderately high Flortaucipir cases (50–75%) were classified as near-saturated (75–100%) by MK6240. Neither raw TSE nor raw SUVR was directly interchangeable across tracers, with systematic and proportional bias for both metrics (MTL Deming slope: TSE 1.29; SUVR 2.69). DISCUSSION: TSE showed stronger unadjusted associations than SUVR in selected region- and outcome-specific comparisons, supporting its potential as a complementary measure. Like SUVR, raw TSE values were not directly interchangeable between flortaucipir and MK6240, and tracer-specific calibration and validation are required before cross-tracer use.Keywords
Funding Information
- National Institute on Aging (R01AG073267)
- National Institute on Aging (U01AG016976)
- National Institute on Aging (U24AG021886)
- Weston Brain Institute
- Alzheimer's Association (24AARFD-1243899)
- Alzheimer's Association (AARFD-22-974627)
- Alzheimer's Association (AARFD-22-923814)
- Alzheimer's Association (AARF-D-23-1150249)
- Canadian Institutes of Health Research
- Fonds de recherche du Québec - Santé
- Colin J. Adair Charitable Foundation
- Fondo de Investigaciones Sanitarias (FIS), Carlos III Health Institute
- CIBERNED (Program 1)
- European Regional Development Fund
- European Union - Horizon 2020 (H2020-SC1-BHC-2018-2020)
- Department de Salut, Generalitat de Catalunya (SLT006/17/00119)
- Fundación Tatiana Pérez de Guzmán el Bueno (IIBSP-DOW-2020-151)
- National Institutes of Health (1R01AG056850-01A1)
- National Institutes of Health (R21AG056974)
- National Institutes of Health (R01AG061566)
- National Institutes of Health (1R01AG081394-01)
- National Institutes of Health (1R61AG066543-01)
- National Institutes of Health (K23-AG076960)
This publication has 34 references indexed in Scilit:
- Design and validation of the ADNI MR protocolAlzheimer's & Dementia, 2024
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupAlzheimer's & Dementia, 2024
- The spatial extent of tauopathy on [18F]MK-6240 tau PET shows stronger association with cognitive performances than the standard uptake value ratio in Alzheimer’s diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 2024
- Donanemab in Early Symptomatic Alzheimer DiseaseJAMA, 2023
- Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer DiseaseJAMA Neurology, 2021
- Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease casesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- Differentiating among stages of cognitive impairment in aging: Version 3 of the Uniform Data Set (UDS) neuropsychological test battery and MoCA index scoresAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2020
- Entorhinal and transentorhinal atrophy in mild cognitive impairment using longitudinal diffeomorphometryAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2017
- In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrumAnnals of Neurology, 2016
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991